secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001193125-22-174863
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences shareholders elect three Class I directors, ratify EY as auditor
--------------------------------------------------------------------------------

- Elisabet de los Pinos, Giovanni Mariggi, Raj Parekh elected as Class I directors with ~18.4M+ votes each.
- Ernst & Young ratified as independent auditor for FY2022; 19,088,824 for, 604 against, 1,963 abstentions.
- Total shares present or represented: 19,091,391 out of 29,222,296 eligible shares.
- No other proposals or material items were voted on at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312522174863/0001193125-22-174863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312522174863/d363493d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-174863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer